|

Daratumumab/daratumumab and hyaluronidase-fihj Clinical Trials

1 actively recruiting trial

Also known as: Dara

Top Sponsors

  • Yongyong MA1

Indications

  • Amyloid Light-chain Amyloidosis1
  • Cancer1

Other1 trial

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.